Acadian Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,309
| Closed | -$23K | – | 2022 |
|
|
2024
Q3 | $23K | Buy |
+2,309
| New | +$23K | ﹤0.01% | 1960 |
|
|
2023
Q4 | – | Sell |
-22,691
| Closed | -$137K | – | 1780 |
|
|
2023
Q3 | $137K | Sell |
22,691
-147,797
| -87% | -$892K | ﹤0.01% | 1258 |
|
|
2023
Q2 | $1.32M | Buy |
170,488
+39,833
| +30% | +$309K | 0.01% | 814 |
|
|
2023
Q1 | $744K | Buy |
130,655
+2,804
| +2% | +$16K | ﹤0.01% | 954 |
|
|
2022
Q4 | $752K | Hold |
127,851
| – | – | ﹤0.01% | 920 |
|
|
2022
Q3 | $408K | Buy |
127,851
+13,635
| +12% | +$43.5K | ﹤0.01% | 1044 |
|
|
2022
Q2 | $511K | Buy |
114,216
+108,709
| +1,974% | +$486K | ﹤0.01% | 964 |
|
|
2022
Q1 | $29K | Buy |
+5,507
| New | +$29K | ﹤0.01% | 1525 |
|